Clinical trials: Autoimmune Hepatitis, open to volunteers
- Condition Autoimmune Hepatitis
- Status Open to volunteers
- Funder type Industry (pharma, biotech, devices)
Autoimmune Hepatitis, AIH
A Trial of Inebilizumab in Participants With Autoimmune Hepatitis
The main objectives of this trial are to evaluate the safety and tolerability of inebilizumab in participants with autoimmune hepatitis (AIH) (Part 1) and to evaluate the efficacy of inebilizumab on AIH disease activity and…
- Trial name
- MERCURY (NCT07598825)
- Testing
- Inebilizumab, Standard of Care
- Where
- 36 sites in United States, Belgium and 6 more
- Volunteers
- 180 people
- Sponsor
- Amgen